## Core Concept
Tumor lysis syndrome (TLS) is a life-threatening complication that occurs when a large number of cancer cells die rapidly, releasing their contents into the bloodstream. This leads to various electrolyte and metabolic abnormalities. The key electrolytes involved in TLS include potassium, phosphate, and calcium.

## Why the Correct Answer is Right
The correct answer, . (Hyperphosphatemia, Hypocalcemia, Hyperkalemia, and Hyperuricemia), is right because TLS results in the release of intracellular contents from lysed cancer cells. This includes:
- **Hyperphosphatemia**: Phosphate is released from lysed cells, leading to elevated serum phosphate levels.
- **Hypocalcemia**: High phosphate levels can bind to calcium, forming calcium phosphate crystals that precipitate out of the blood, lowering serum calcium levels.
- **Hyperkalemia**: Potassium is also released from lysed cells, leading to elevated serum potassium levels.
- **Hyperuricemia**: The breakdown of nucleic acids from cancer cells results in the production of uric acid, which can exceed the kidney's ability to excrete it, leading to hyperuricemia.

## Why Each Wrong Option is Incorrect
- **Option A:** (Hypercalcemia) is incorrect because TLS is associated with hypocalcemia, not hypercalcemia, due to the precipitation of calcium phosphate.
- **Option B:** (Hypokalemia) is incorrect because TLS leads to hyperkalemia, not hypokalemia, as potassium is released from lysed cells.
- **Option C:** (Hypophosphatemia) is incorrect because TLS results in hyperphosphatemia due to the release of phosphate from cancer cells.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is to recognize that TLS can lead to acute kidney injury (AKI) due to the precipitation of uric acid and calcium phosphate crystals in the renal tubules. Early recognition and aggressive management of electrolyte abnormalities and hydration are crucial to prevent complications.

## Correct Answer Line
**Correct Answer: .**